HCPLive Network

Product News

The US Food and Drug Administration announced the approval of Jardiance (empagliflozin) to treat adults with type 2 diabetes.
The US Food and Drug Administration announced the approval of a new drug for the treatment of chronic obstructive pulmonary disease.
If the results of recent trials in Asia can be applied to the larger medical marketplace there could be a powerful new weapon in the fight against malaria.
The US Food and Drug Administration recently approved a treatment for 3 forms of blood cancers.
As it continues to tackle the issue of prescription drug abuse, the US Food and Drug Administration today approved an extended-release/long-acting opioid analgesic designed to help chronic pain patients while curbing their ability to tamper with it.
A wearable device for managing diabetic peripheral neuropathy has been cleared by the US Food and Drug Administration.
In 2 recent clinical trials, a treatment for young patients diagnosed with attention deficit hyperactivity disorder reportedly demonstrated benefit over another currently used ADHD medication.
The US Food and Drug Administration recently approved a new drug aimed to aid the thousands of Americans affected by hereditary angioedema.
A new drug has been designated a Qualified Infectious Disease Product by the US Food and Drug Administration to treat patients diagnosed with invasive candidiasis.
$AD300x250BB$